Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 31.3% Profit

May 03, 2023
On February 17, 2023, QuantWave issued a long signal for ELI LILLY AND COMPANY stock when it was trading at $322.91. The forecast proved to be accurate as the stock reached the target price of $423.98 on May 3, 2023, resulting in a profitable gain of 31.3%.

This achievement highlights QuantWave's effectiveness in providing precise and actionable predictions for investors. The successful forecast for ELI LILLY AND COMPANY demonstrates the platform's ability to analyze market trends and identify profitable trading opportunities.

Several factors may have contributed to ELI LILLY AND COMPANY's price movement, including positive earnings reports, strategic business decisions, and industry developments. Investors who followed QuantWave's forecast would have capitalized on these price movements and generated substantial profits.

QuantWave offers a reliable and efficient automated forecasting platform that allows users to access predictions for a wide range of stocks. This presents valuable opportunities for investors seeking to maximize their returns and make informed trading decisions. For those interested in enhancing their investment strategy, QuantSchool provides comprehensive educational resources to help users understand the key principles behind the QuantWave forecasting system and achieve consistent income.

Overall, the successful price target forecast for ELI LILLY AND COMPANY stock underscores the benefits of utilizing QuantWave's analytics in navigating the financial markets and achieving profitable outcomes.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

BTC-USDNovember 9, 2022QuantWave Successfully Achieves 29.65% Profit Target for BITCOIN USD Forecast  ~1 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics for the stock BITCOIN USD....

UNHJuly 17, 2024UNITEDHEALTH GROUP INC. Hits Price Target Forecast with 12.03% Profit — A Success Story for QuantWave  ~1 min.

UNITEDHEALTH GROUP INC. has seen a significant price movement in line with QuantWave's forecast, reaching the predicted target price with a profit of 12.03%....

CRMDecember 18, 2023SALESFORCE, INC. Stock Hits QuantWave's Price Target Forecast with 22.2% Profit  ~1 min.

SALESFORCE, INC. (CRM) investors rejoiced as QuantWave's forecast signal successfully reached its price target, delivering a substantial 22.2% profit....

GEJune 2, 2025QuantWave Forecasts Achieve 48.5% Profit Target for GE AEROSPACE Stock  ~1 min.

QuantWave's automated forecasting platform recently achieved a significant milestone with its prediction for GE AEROSPACE stock, delivering a profit of 48.5% for investors....

ALBApril 4, 2025ALBEMARLE CORPORATION Hits Target Forecast with 50.49% Profit Margin  ~2 min.

On April 30, 2024, QuantWave issued a short forecast signal for ALBEMARLE CORPORATION with a price of $118.18. The prediction proved accurate as the stock reached the target price of $58....